If you liked this article you might like

Biotech Movers: Organovo, Endo, Omeros
Biotech Movers: Ultragenyx Jumps on Phase Three Burosumab Data
Endo international, AngioDynamics Lead Biotech Movers
FDA deals blow to Endo over Opana ER Pain Med